LifeStance Health (LFST) Revenue (2020 - 2026)

LifeStance Health (LFST) has 7 years of Revenue data on file, last reported at $403.5 million in Q1 2026.

• Quarterly Revenue rose 21.17% year-over-year to $403.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.5 billion (up 16.46% YoY) and the FY2025 annual result came in at $1.4 billion, up 13.85% from the prior year.
• Revenue rose to $403.5 million in Q1 2026 per LFST's latest filing, from $382.2 million in the prior quarter.
• Across five years, Revenue topped out at $403.5 million in Q1 2026 and bottomed at $203.1 million in Q1 2022.
• The 5-year median for Revenue is $300.4 million (2024), against an average of $293.8 million.
• The widest annual swing landed in 2022, when Revenue jumped 41.89%; it then grew 10.56% in 2025.
• Tracing LFST's Revenue over 5 years: stood at $229.4 million in 2022, then gained by 22.34% to $280.6 million in 2023, then grew by 15.99% to $325.5 million in 2024, then gained by 17.43% to $382.2 million in 2025, then gained by 5.57% to $403.5 million in 2026.
• Per Business Quant, the three latest LFST Revenue figures stand at $403.5 million (Q1 2026), $382.2 million (Q4 2025), and $363.8 million (Q3 2025).

Peer Comparison